Source-grounded facts extracted from OMEGA HEALTHCARE INVESTORS INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
OMEGA HEALTHCARE INVESTORS INC shareholders approved Advisory Vote on Executive Compensation at the 2026-06-05 meeting.
“Proposal 3: Advisory Vote on Executive Compensation For Against Abstentions Broker Non-Votes 202,883,780 10,248,851 966,672 41,826,987”
OMEGA HEALTHCARE INVESTORS INC shareholders approved Proposal to Ratify the Selection of Ernst & Young LLP as Omega's Independent Registered Public Accounting Firm for the Year Ending December 31, 2026 at the 2026-06-05 meeting.
“Proposal 2: Proposal to Ratify the Selection of Ernst & Young LLP as Omega’s Independent Registered Public Accounting Firm for the Year Ending December 31, 2026 For Against Abstentions Broker Non-Votes 240,521,117 14,949,017 456,156 Not applicable”
OMEGA HEALTHCARE INVESTORS INC shareholders approved Election of Directors at the 2026-06-05 meeting.
“Proposal 1: Election of Directors FOR AGAINST ABSTENTIONS BROKER NON-VOTES Kapila K. Anand 207,267,529 6,458,915 372,859 41,826,987 Craig R. Callen 206,030,608 7,709,158 359,537 41,826,987 Dr. Lisa C. Egbuonu-Davis 209,507,298 3,824,288 767,717 41,826,987 Barbara B. Hill 206,904,705 6,837,458 357,140 41,826,987 Kevin J. Jacobs 212,039,448 1,703,885 355,970 41,826,987 C. Taylor Pickett 211,101,005 2,613,356 384,942 41,826,987 Stephen D. Plavin 198,442,058 15,286,082 371,163 41,826,987 Burke W. Whitman 208,122,149 5,606,187 370,967 41,826,987”
Lucas M. Golem was appointed as Chief Accounting Officer at OMEGA HEALTHCARE INVESTORS INC.
“Lucas M. Golem, the Company’s Vice President of Financial Reporting, to succeed Mr. Ballew’s position and serve as the Company’s Chief Accounting Officer”
Neal A. Ballew changed role as Chief Financial Officer at OMEGA HEALTHCARE INVESTORS INC.
“The Board also appointed Neal A. Ballew, the Company’s Senior Vice President and Chief Accounting Officer, to serve as the Company’s Chief Financial Officer”
Matthew P. Gourmand was appointed as President and Chief Executive Officer at OMEGA HEALTHCARE INVESTORS INC.
“The Board also appointed Matthew P. Gourmand, the Company’s President, to serve as the Company’s President and Chief Executive Officer, effective as of the CEO Transition Date.”
Robert O. Stephenson departed as Chief Financial Officer at OMEGA HEALTHCARE INVESTORS INC.
“on May 19, 2026, the Board and Robert O. Stephenson mutually agreed that Mr. Stephenson’s employment with the Company will terminate effective August 1, 2026”
C. Taylor Pickett departed as member of the Board at OMEGA HEALTHCARE INVESTORS INC.
“position as a member of the Board will terminate effective October 1, 2026”
C. Taylor Pickett departed as Chief Executive Officer at OMEGA HEALTHCARE INVESTORS INC.
“On May 19, 2026, the Board and C. Taylor Pickett, the Company’s Chief Executive Officer, mutually agreed that Mr. Pickett’s employment with the Company and position as a member of the Board will terminate effective October 1, 2026”
OMEGA HEALTHCARE INVESTORS INC reported the quarter ended March 31, 2026 results: net income $159 million, EPS $0.47 per diluted share. Guidance raised.
“(NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter ended March 31, 2026. FIRST QUARTER 2026 AND RECENT HIGHLIGHTS ● Net income for the quarter of $159 million, or $0.47 per diluted share, compared to $112 million, or $0.33 per diluted share, for Q1 2025. ● Adjusted Funds From Operations (“Adjusted FFO” or “AFFO”) for the quarter of”
OMEGA HEALTHCARE INVESTORS INC incurred senior notes of $600 million aggregate principal amount with U.S. Bank Trust Company, National Association at 5.200% per annum maturing July 1, 2030.
“completed an underwritten public offering of $600 million aggregate principal amount of its 5.200% Senior Notes due 2030”
Daniel J. Booth was terminated as Chief Operating Officer at OMEGA HEALTHCARE INVESTORS INC.
“the Company and Daniel J. Booth, the Company’s Chief Operating Officer, mutually agreed that Mr. Booth’s employment with the Company would terminate effective January 2, 2025.”
Vikas Gupta was appointed as Chief Investment Officer at OMEGA HEALTHCARE INVESTORS INC.
“the Board appointed Vikas Gupta, previously the Company’s Senior Vice President of Acquisitions & Development, as Chief Investment Officer of the Company.”
Matthew Gourmand was appointed as President at OMEGA HEALTHCARE INVESTORS INC.
“the Board of Directors (the “Board”) of Omega Healthcare Investors, Inc. (the “Company”) appointed Matthew Gourmand, previously the Company’s Senior Vice President of Corporate Strategy & Investor Relations, as President of the Company.”
OMEGA HEALTHCARE INVESTORS INC reported quarter ended September 30, 2023 results: net income $0.37 per common share.
“Omega Healthcare Investors, Inc. (“Omega”) issued a press release regarding its financial results for the quarter ended September 30, 2023.”
OMEGA HEALTHCARE INVESTORS INC entered into Credit Agreement with a syndicate of financial institutions, as lenders, and Bank of America, N.A., as administrative agent valued at $400 million (effective 2023-08-08).
“On August 8, 2023, Omega Healthcare Investors, Inc. (" Omega " or the " Company ") obtained a new $400 million senior unsecured term loan (the " Term Loan ").”
OMEGA HEALTHCARE INVESTORS INC reported the quarter ended June 30, 2023 results: net income $62 million, or $0.25 per common share.
“Net income for the quarter of $62 million, or $0.25 per common share, compared to $92 million, or $0.38 per common share, for the same period in 2022.”
OMEGA HEALTHCARE INVESTORS INC shareholders approved Approval of Amendment to the 2018 Stock Incentive Plan.
“Proposal 5: Approval of Amendment to the 2018 Stock Incentive Plan For Against Abstentions Broker Non-Votes 127,093,031 7,314,929 862,157 47,824,076”
OMEGA HEALTHCARE INVESTORS INC shareholders approved Advisory Vote on Frequency of Advisory Vote on Executive Compensation.
“Proposal 4: Advisory Vote on Frequency of Advisory Vote on Executive Compensation One Year Two Years Three Years Abstentions 129,618,983 689,914 4,264,868 696,353”
OMEGA HEALTHCARE INVESTORS INC shareholders approved Advisory Vote on Executive Compensation.
“Proposal 3: Advisory Vote on Executive Compensation For Against Abstentions Broker Non-Votes 126,119,015 8,026,106 1,124,996 47,824,076”
OMEGA HEALTHCARE INVESTORS INC shareholders approved Ratification of Selection of Ernst & Young LLP as Independent Auditor for Fiscal Year 2023.
“Proposal 2: Proposal to Ratify the Selection of Ernst & Young LLP as Omega’s Independent Auditor for Fiscal Year 2023 For Against Abstentions Broker Non-Votes 172,580,472 9,747,051 766,670 Not applicable”
OMEGA HEALTHCARE INVESTORS INC shareholders approved Election of Directors.
“Proposal 1: Election of Directors For Against Abstentions Broker Non-Votes Kapila K. Anand 130,901,396 3,786,924 581,797 47,824,076 Craig R. Callen 131,401,553 3,301,809 566,755 47,824,076 Dr. Lisa C. Egbuonu-Davis 131,468,497 3,257,452 544,168 47,824,076 Barbara B. Hill 131,634,889 3,104,292 530,936 47,824,076 Kevin J. Jacobs 133,051,160 1,659,327 559,630 47,824,076 C. Taylor Pickett 132,788,404 1,910,693 571,020 47,824,076 Stephen D. Plavin 125,996,653 8,708,839 564,625 47,824,076 Burke W. Whitman 131,640,170 3,055,166 574,811 47,824,076”
OMEGA HEALTHCARE INVESTORS INC reported quarter ended March 31, 2023 results: net income $37 million, EPS $0.15 per common share.
“Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter ended March 31, 2023. FIRST QUARTER 2023 AND RECENT HIGHLIGHTS ● Net income for the quarter of $37 million, or $0.15 per common share.”
OMEGA HEALTHCARE INVESTORS INC reported the year ended December 31, 2022 results: net income $439 million, or $1.80 per common share, EPS $1.80 per common share.
“Net income for the year of $439 million, or $1.80 per common share, compared to $428 million, or $1.75 per common share, for the same period in 2021.”
OMEGA HEALTHCARE INVESTORS INC reported the quarter ended December 31, 2022 results: net income $47 million, or $0.19 per common share, EPS $0.19 per common share.
“Net income for the quarter of $47 million, or $0.19 per common share, compared to $34 million, or $0.14 per common share, for the same period in 2021.”
OMEGA HEALTHCARE INVESTORS INC reported quarter ended September 30, 2022 results: net income $105 million, EPS $0.43 per common share.
“Net income for the quarter of $105 million, or $0.43 per common share, compared to $143 million, or $0.58 per common share, for the same period in 2021.”
Steven J. Insoft was terminated as Chief Corporate Development Officer at OMEGA HEALTHCARE INVESTORS INC.
“On December 31, 2021, Omega Healthcare Investors, Inc. (the “Company”) and Mr. Steven J. Insoft, the Company’s Chief Corporate Development Officer, mutually agreed that Mr. Insoft’s employment with the Company will terminate effective January 1, 2022.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.